RXi Pharmaceuticals News

Galena Biopharma Inc. reported that its net losses for the most recent quarter escalated sixfold over the company's 2011 figures.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia LAKE OSWEGO, Ore., May 10, 2012 -- Galena Biopharma , a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical ... (more)

WORCESTER, Mass. -- -- RXi Pharmaceuticals Corporation announced today that the Financial Industry Regulatory Authority, Inc., also known as FINRA, has approved RXi Pharmaceuticals' common stock for trading under the stock symbol "RXII" on the OTC Bulletin Board.

WORCESTER, Mass. -- -- RXi Pharmaceuticals Corporation today announced that Geert Cauwenbergh, Dr.

LAKE OSWEGO, Ore., May 9, 2012 -- Galena Biopharma , a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Operating Officer, will give a presentation entitled, "Phase II ... (more)

Galena Biopharma , a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, announced upcoming presentations at the American Society of Clinical Oncology 2012 Annual Meeting. The annual event is being held June 1-5, 2012 in Chicago, Illinois.

Galena Biopharma is a biotechnology company focused on discovering, developing, and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia LAKE OSWEGO, Ore., May 1, 2012 -- Galena Biopharma, Inc.